Study to Assess the Safety and Effectiveness of NMRA-335140-501
NCT06029439
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
1000
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
NMRA-335140
Sponsor
Neumora Therapeutics, Inc.